179 related articles for article (PubMed ID: 28002623)
1. Comprehensive screening for MED12 mutations in gynaecological mesenchymal tumours identified morphologically distinctive mixed epithelial and stromal tumours.
Yuan CT; Huang WC; Lee CH; Lin MC; Lee CH; Kao YC; Huang HY; Kuo KT; Lee JC
Histopathology; 2017 May; 70(6):954-965. PubMed ID: 28002623
[TBL] [Abstract][Full Text] [Related]
2. Detection of MED12 mutations in mesenchymal components of uterine adenomyomas.
Kito M; Maeda D; Kudo-Asabe Y; Tamura D; Makino K; Sageshima M; Nanjo H; Terada Y; Goto A
Hum Pathol; 2021 Mar; 109():31-36. PubMed ID: 33259844
[TBL] [Abstract][Full Text] [Related]
3. MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression.
Tan WJ; Chan JY; Thike AA; Lim JC; Md Nasir ND; Tan JS; Koh VC; Lim WK; Tan J; Ng CC; Rajasegaran V; Nagarajan S; Bay BH; Teh BT; Tan PH
J Clin Pathol; 2016 Oct; 69(10):858-65. PubMed ID: 27056456
[TBL] [Abstract][Full Text] [Related]
4. Frequent MED12 mutations in phyllodes tumours of the breast.
Yoshida M; Sekine S; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Ochiai A
Br J Cancer; 2015 May; 112(10):1703-8. PubMed ID: 25839987
[TBL] [Abstract][Full Text] [Related]
5. MED12 exon 2 mutations in phyllodes tumors of the breast.
Nagasawa S; Maeda I; Fukuda T; Wu W; Hayami R; Kojima Y; Tsugawa K; Ohta T
Cancer Med; 2015 Jul; 4(7):1117-21. PubMed ID: 25865354
[TBL] [Abstract][Full Text] [Related]
6. Frequency of known gene rearrangements in endometrial stromal tumors.
Chiang S; Ali R; Melnyk N; McAlpine JN; Huntsman DG; Gilks CB; Lee CH; Oliva E
Am J Surg Pathol; 2011 Sep; 35(9):1364-72. PubMed ID: 21836477
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.
Matsubara A; Sekine S; Yoshida M; Yoshida A; Taniguchi H; Kushima R; Tsuda H; Kanai Y
Histopathology; 2013 Mar; 62(4):657-61. PubMed ID: 23347103
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait.
Ali RH; Al-Safi R; Al-Waheeb S; John B; Al-Ali W; Al-Jassar W; Al-Mulla F; Melnyk N; Huntsman DG; Lee CH
Hum Pathol; 2014 Dec; 45(12):2453-62. PubMed ID: 25288234
[TBL] [Abstract][Full Text] [Related]
9. MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases.
Ng CC; Tan J; Ong CK; Lim WK; Rajasegaran V; Nasir ND; Lim JC; Thike AA; Salahuddin SA; Iqbal J; Busmanis I; Chong AP; Teh BT; Tan PH
J Clin Pathol; 2015 Sep; 68(9):685-91. PubMed ID: 26018969
[TBL] [Abstract][Full Text] [Related]
10. MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.
Piscuoglio S; Murray M; Fusco N; Marchiò C; Loo FL; Martelotto LG; Schultheis AM; Akram M; Weigelt B; Brogi E; Reis-Filho JS
Histopathology; 2015 Nov; 67(5):719-29. PubMed ID: 25855048
[TBL] [Abstract][Full Text] [Related]
11. YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
Isphording A; Ali RH; Irving J; Goytain A; Nelnyk N; Hoang LN; Gilks CB; Huntsman DG; Nielsen TO; Nucci MR; Lee CH
Hum Pathol; 2013 May; 44(5):837-43. PubMed ID: 23159154
[TBL] [Abstract][Full Text] [Related]
12. MED12 is frequently mutated in ovarian and other adnexal leiomyomas.
Li Z; Maeda D; Kudo-Asabe Y; Tamura D; Nanjo H; Hayashi A; Ikemura M; Fukayama M; Goto A
Hum Pathol; 2018 Nov; 81():89-95. PubMed ID: 29944972
[TBL] [Abstract][Full Text] [Related]
13. Recurrent
Pareja F; Da Cruz Paula A; Murray MP; Hoang T; Gularte-Mérida R; Brown D; da Silva EM; Sebastiao APM; Giri DD; Weigelt B; Reis-Filho JS; Brogi E
J Clin Pathol; 2019 Mar; 72(3):258-262. PubMed ID: 30467240
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis.
Lien HC; Huang CS; Yang YW; Jeng YM
Histopathology; 2016 Feb; 68(3):433-41. PubMed ID: 26109290
[TBL] [Abstract][Full Text] [Related]
15. MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast.
Lien HC; Huang CS; Yang YW; Jeng YM
APMIS; 2016 May; 124(5):356-64. PubMed ID: 26860948
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.
Je EM; Kim MR; Min KO; Yoo NJ; Lee SH
Int J Cancer; 2012 Sep; 131(6):E1044-7. PubMed ID: 22532225
[TBL] [Abstract][Full Text] [Related]
17. Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.
Kämpjärvi K; Mäkinen N; Kilpivaara O; Arola J; Heinonen HR; Böhm J; Abdel-Wahab O; Lehtonen HJ; Pelttari LM; Mehine M; Schrewe H; Nevanlinna H; Levine RL; Hokland P; Böhling T; Mecklin JP; Bützow R; Aaltonen LA; Vahteristo P
Br J Cancer; 2012 Nov; 107(10):1761-5. PubMed ID: 23132392
[TBL] [Abstract][Full Text] [Related]
18. Stromal
da Silva EM; Beca F; Sebastiao APM; Murray MP; Silveira C; Da Cruz Paula A; Pareja F; Wen HY; D'Alfonso TM; Edelweiss M; Weigelt B; Brogi E; Reis-Filho JS; Zhang H
J Clin Pathol; 2022 Feb; 75(2):133-136. PubMed ID: 33376197
[TBL] [Abstract][Full Text] [Related]
19. Mullerian adenosarcoma of the female genital tract.
McCluggage WG
Adv Anat Pathol; 2010 Mar; 17(2):122-9. PubMed ID: 20179434
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases.
Stewart CJ; Leung YC; Murch A; Peverall J
Histopathology; 2014 Oct; 65(4):473-82. PubMed ID: 24592973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
